Patents by Inventor Bard Indrevall

Bard Indrevall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9533059
    Abstract: The present invention relates to imaging agent compositions comprising radiolabelled c-Met binding peptides suitable for positron emission tomography (PET) imaging in vivo. The c-Met binding peptides are labelled with the radioisotope 18F. Also disclosed are pharmaceutical compositions, methods of preparation of the agents and compositions, plus methods of in vivo imaging using the compositions, especially for use in the management of cancer.
    Type: Grant
    Filed: August 11, 2011
    Date of Patent: January 3, 2017
    Assignee: GE HEALTHCARE LIMITED
    Inventors: Peter Brian Iveson, Rajiv Bhalla, Bard Indrevall, Gareth Getvoldsen
  • Publication number: 20130149241
    Abstract: The present invention relates to imaging agent compositions comprising radiolabelled c-Met binding peptides suitable for positron emission tomography (PET) imaging in vivo. The c-Met binding peptides are labelled with the radioisotope 18F. Also disclosed are pharmaceutical compositions, methods of preparation of the agents and compositions, plus methods of in vivo imaging using the compositions, especially for use in the management of cancer.
    Type: Application
    Filed: August 11, 2011
    Publication date: June 13, 2013
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Peter Brian Iveson, Rajiv Bhalla, Bard Indrevall, Gareth Getvoldsen